NCT01691079View on ClinicalTrials.gov

Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Bronchospasm, Exercise-Induced
Interventions
DRUG

ipratropium bromide

Inhaled ipratropium bromide administered before exercise.

DRUG

Placebo

Inhaled placebo administered before exercise.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT01691079 - Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes | Biotech Hunter | Biotech Hunter